Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivolumab for Hospitalized Obese COVID-19 Patients
NCT04413838Phase 2Unknown
- Sponsor
- Hospices Civils de Lyon
- Start
- Jun 2020
- Primary completion
- Jun 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of nivolumab in coronavirus disease 2019 (COVID-19), sponsored by Hospices Civils de Lyon. Status: unknown.
02
Drugs
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04413838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04413838.